· · · · · 

The FDA Needs an Action Plan for More Inclusive Clinical Trials

If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.

If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.

· · · · · 

Eggs for Cash: Pitting Choice Against Risk

Comprehensive studies on the health effects of providing eggs are essential for young women to make informed choices.

We applaud the California governor’s veto of AB 926, which would have permitted researchers to pay women for their eggs. His decision was based, in part, on the fact that the risks to women who provide eggs outweigh the potential scientific benefits.

· · · · · 

Sexual Health Roundup: The Sexual Power of Penicillin, the Importance of the First Time, and Testosterone Release

(NG Pharmaceutical)

In this week’s sexual health roundup: A pill may have led to the sexual revolution, but it was penicillin – not birth control; new research says the first time a person has sex really is important; and testosterone release is immediate upon mutual attraction. 

· · · · · 

Anatomical Evidence: Will It Settle the G-Spot Debate?

According to an upcoming issue of The Journal of Sexual Medicine, the G spot does, indeed, have an anatomic existence. Others disagree. Perhaps knowing it and understanding it goes beyond anything you can dissect or measure. It’s an untouchable pathway to bliss and the cosmos, making it something so much more.

· · · · ·